Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alibaba Health Information TechnologyALBHF 51 Earnings Yield (Joel Greenblatt) % is 4.04% as of Mar. 2026, which is 40300% above its 10-year median of 0.01. GuruFocus rates ALBHF with a GF Score™ of 51/100 and a GF Value™ of $0.72 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 65.98% on this metric.
The historical rank and industry rank for Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ALBHF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1.07 Med: 0.01 Max: 6.76
Current: 6.17
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Alibaba Health Information Technology was 6.76%. The lowest was -1.07%. And the median was 0.01%.
ALBHF's Earnings Yield (Joel Greenblatt) % is ranked better than 65.98% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 3.735
vs ALBHF: 6.17
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Alibaba Health Information Technology's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Alibaba Health Information Technology (OTCPK:ALBHF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Earnings Yield (Joel Greenblatt) % Chart
Alibaba Health Information Technology Earnings Yield (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) % falls into.
Alibaba Health Information Technology Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 4.04% mean?
Alibaba Health Information Technology (ALBHF) has a Earnings Yield (Joel Greenblatt) % of 4.04% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Alibaba Health Information Technology and its competitors. This is 40300% above median its historical median of 0.01. According to the industry distribution chart, Alibaba Health Information Technology ranks #232 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 34%.
Is Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) % too high?
Alibaba Health Information Technology's current Earnings Yield (Joel Greenblatt) % of 4.04% is 40300% above median its 10-year median of 0.01. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.74. Alibaba Health Information Technology's value of 4.04% is 8.2% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #232 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Alibaba Health Information Technology has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Earnings Yield (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #232 out of 682 companies for Earnings Yield (Joel Greenblatt) %. This puts Alibaba Health Information Technology in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.74. Alibaba Health Information Technology's value of 4.04% is 8.2% above this benchmark. While the company's 10-year median is 0.01 vs. the industry median of 3.74, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.74, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Earnings Yield (Joel Greenblatt) % of 4.04% is 8.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Earnings Yield (Joel Greenblatt) % is 4.04%, which is 40300% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.72, compared to a current price of $0.44 — trading 38.9% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 4.04%, which is 40300% above median its 10-year median of 0.01 and 8.2% above the Healthcare Providers & Services industry median of 3.74. Alibaba Health Information Technology's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Earnings Yield (Joel Greenblatt) % is 4.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.44 is trading 38.9% below its estimated GF Value™ of $0.72.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
Earnings Yield (Joel Greenblatt) %: 4.04% (40300% above median its 10-year median of 0.01)
GF Value™: $0.72 vs. price of $0.44 (38.9% below fair value)
Industry Position: 8.2% above the Healthcare Providers & Services median (#232 of 682)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
51GF Score
Get the complete analysis for ALBHF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
